1. Barnes TRE (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672–676
2. Bunney WE, Meltzer HY (1995) Schizophrenia—overview. Clin Neurosci 3:55–56
3. Burris KD, Molski TF, Ryan E, Xu C, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2000) Aripiprazole is a high affinity partial agonist at human D2 dopamine receptors. Int J Psychopharmacol 3:S129
4. Carson WH, McQuade RD, Ali M, Saha AR, Dunbar GC, Ingenito GA (2001) A double-blind, placebo-controlled trial of aripiprazole and haloperidol. Schizophrenia Res (Special Issue VIIIth International Congress on Schizophrenia Research, Whistler, British Columbia, Canada) 49:221
5. Carson WH, Stock E, Saha AR, Ali M, McQuade RD, Kujawa MJ, Ingenito G (2002) Meta-analysis of safety and tolerability with aripiprazole. Abstracts of the XIth Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, February 24–March 1 2002. Schizophr Res 53:1–274